Developer docs
API playgroundTry for free, no card

Search company profiles

Quantori

Full company profile

uuid0004y1a

Namestring
Quantori
Legal namestring
Quantori, LLC
Websiteurl
quantori.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Quantori is a private, Cambridge, Massachusetts-headquartered software and digital services firm that builds AI-enabled solutions for life sciences and healthcare R&D. The company employs 750+ data scientists, data engineers, and domain experts (with more than 15% holding MDs or PhDs) and serves 12 of the 15 largest global pharmaceutical companies alongside 20+ mid-market and startup biotech clients, including Pfizer, AstraZeneca, Eli Lilly, Novartis, Bristol Myers Squibb, Takeda, Biogen, Genentech, Gilead, Syngenta, BioNTech, Bruker, PerkinElmer, LGC, and JAX.

The company's flagship product is Q-Suite, a modular agentic AI platform consisting of Q-Scientist (enterprise AI and data platform for multi-omics and LLM-powered analysis), Q-Models (ADMET prediction ML suite, co-developed with Expert Systems), Q-Portal (governed LLM deployment for regulated environments), Q-Discover (agentic drug discovery and computational chemistry), Q-HPC (computational infrastructure orchestration), Q-Data (unified life sciences data foundation), and Q-Image (4D medical imaging analytics). The platform integrates with on-prem, cloud, and hybrid environments and supports multimodal AI across text, imaging, and structured scientific data.

Quantori monetizes through a hybrid model: professional services and consulting (digital transformation, data engineering, scientific informatics, cloud engineering) and subscription/recurring revenue from Q-Suite platform products. Distribution is enterprise-direct via a 'Schedule Consultation' sales motion, complemented by AWS Advanced Services, Azure, GCP, Databricks, Snowflake, and Atlassian partnerships, AWS Marketplace listing, and a multi-channel marketing program including proprietary roundtables, industry conferences, and scientific content. The company is backed by a $15 million Flint Capital investment (October 2022) at a $100 million post-money valuation and holds ISO 27001 and AICPA SOC certifications.

Short descriptiontext

Quantori is a Cambridge, MA-based software and digital services firm that builds AI-enabled solutions (Q-Suite platform) for life sciences and healthcare R&D, serving 12 of the 15 largest pharmaceutical companies plus biotech, instruments, and research clients globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life sciences software, drug discovery AI, biopharma data science, R&D informatics, computational chemistry platform
Industry4 codes
PRIMARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYBPAEAHAF
AI/ML Engineering & Model Development Services
SECONDARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAAACAO
Enterprise Foundation Model Integration & APIs (Connectors, Governance, Deployment)
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Foundation Models & Generative AI (LLMs, multimodal)
NAICS code3 codes
  • Custom Computer Programming Services541511
  • Software Publishers513210
  • Computer Systems Design Services541512
SIC code2 codes
  • Services-Computer Programming Services7371
  • Services-Prepackaged Software7372
Product category
Life Sciences R&D Software & Digital Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Digital Services and Consulting
TypeProfessional Services
Description

End-to-end digital transformation and AI-driven solutions for life sciences and healthcare companies. Professional services including software engineering, scientific informatics, data science, and cloud engineering.

quantori.com
2Q-Suite Platform Products
TypeSubscription Recurring
Description

AI-enabled platform products and accelerators (Q-Scientist, Q-Discover, Q-Models, Q-HPC, Q-Portal, Q-Data, Q-Image) delivered as enterprise software solutions.

quantori.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Quantori builds and sells the Q-Suite modular agentic AI platform for life sciences R&D, comprising Q-Scientist, Q-Models, Q-Portal, Q-Discover, Q-HPC, Q-Data, and Q-Image, alongside complementary digital IT, scientific informatics, data science, cloud engineering, and software development services for pharmaceutical, biotechnology, and healthcare customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Serving 12 of 15 largest pharmaceutical companies globally
+3 more records
Product overview1 text field

Quantori offers Q-Suite, a modular agentic AI platform for life sciences R&D, consisting of core flagship accelerators (Q-Scientist, Q-Models, Q-Portal) plus additional specialized modules (Q-Discover, Q-HPC, Q-Data, Q-Image). The platform combines deep domain expertise with advanced engineering to build AI-enabled digital solutions for healthcare and life sciences. Q-Scientist serves as the enterprise AI and data platform, Q-Models provides ADMET prediction ML models, and Q-Portal governs LLM usage in regulated environments. Additional modules include Q-Discover for drug discovery workflows, Q-HPC for computational infrastructure optimization, Q-Data for unified data foundations, and Q-Image for medical imaging analysis. Quantori also offers standalone API products like the ML Conformer Generator and Deck.AI enterprise knowledge management tool.

Product and service10 records
1Q-Scientist
CategoryQ-Suite Platform / R&D AI Platform
Description

Enterprise-grade AI and data platform that lets scientific teams run advanced R&D workflows, from multi-omics to LLM-powered analysis, through a modular interface with secure integration into existing on-prem, cloud, or hybrid infrastructure.

2Q-Models
CategoryQ-Suite Platform / Predictive ML Models
Description

Comprehensive suite of machine learning models for predicting absorption, distribution, metabolism, excretion, and toxicity (ADMET) in drug discovery, delivered as a core service within the modular Q-Suite architecture.

3Q-Portal
CategoryQ-Suite Platform / LLM Governance
Description

Enterprise-ready platform for securely introducing and managing Large Language Model capabilities across pharmaceutical and healthcare organizations, providing a governed, compliance-aware environment for Generative AI with sensitive data.

4Q-Discover
CategoryQ-Suite Platform / Drug Discovery AI
Description

End-to-end agentic AI platform that accelerates and streamlines the drug discovery and computational chemistry pipeline, integrating AI/ML molecular design, high-performance computing, and multi-agent workflow orchestration.

5Q-HPC
CategoryQ-Suite Platform / HPC Orchestration
Description

Agentic platform that automatically manages, optimizes, and scales computational infrastructure required for demanding scientific research, replacing manual resource allocation with intelligent, unified systems.

6Q-Data
CategoryQ-Suite Platform / Data Foundation
Description

Enterprise-grade data platform that transforms fragmented life sciences data into a unified, AI-ready foundation for accelerated discovery, with intelligent automation that eliminates data preparation bottlenecks.

7Q-Image
CategoryQ-Suite Platform / Medical Imaging AI
Description

Unified AI-powered platform that transforms medical imaging from static moments into interactive 4-dimensional (3D space + Time) longitudinal models, integrating images from disparate sensors and sources.

8ML Conformer Generator API Inference Server
CategoryAPI Product / Computational Chemistry
Description

Advanced API-based solution designed to accelerate small molecule discovery through 3D shape-constrained generation of molecular conformers.

9Deck.AI
CategoryEnterprise Knowledge Management Software
Description

Enterprise-level knowledge management tool designed to streamline the process of creating and managing presentations for life sciences and healthcare organizations.

10Digital Services and Consulting
CategoryProfessional Services / Digital IT & Data Science
Description

End-to-end digital transformation and AI-driven professional services for life sciences and healthcare customers, including software engineering, scientific informatics, data science, cloud engineering, and DevOps.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-11
Description

Strategic partnership to deploy Google Cloud-native integrated AI-driven peptide design and molecular simulation platform. The platform integrates advanced protein folding models, molecular dynamics simulations, and AI into Decoy's proprietary IMP3ACT design engine. Expected to increase computational throughput by 25- to 100-fold.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-18
Description

Strategic partnership to develop and integrate foundational predictive AI models for pharmaceutical research and development. Collaboration aims to improve drug discovery processes by forecasting outcomes and accelerating workflows, potentially reducing development time and costs.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-01-01
Description

Co-marketing partnership to advance knowledge-driven AI in life sciences. Together, Quantori and Knowledge3 aim to help organizations move beyond fragmented data environments and siloed AI initiatives.

Strategic tierCoreTypeTechnology or Integration
Description

Cloud platform partner providing infrastructure for AI-driven solutions. Google Cloud funding supports partnerships like the Decoy Therapeutics collaboration. Quantori is recognized as having deep GCP expertise.

Strategic tierCoreTypeTechnology or Integration
Description

AWS Advanced Services Partner with over 20 years of superior software engineering skills combined with AWS technologies. Team of AWS-certified engineers with special expertise in healthcare and life sciences. Achieved 50 AWS certifications milestone.

6Microsoft Azure
Strategic tierCoreTypeTechnology or Integration
Description

Cloud platform partner offering Azure-based digital transformation and cloud consulting services for life sciences and healthcare organizations.

quantori.com
Strategic tierNotableTypeStrategic or Co-development Partner
Description

ImmuVia selected Quantori's Q-Scientist platform to streamline computational workflows across its preclinical programs for first-in-class cancer therapy development.

Strategic tierNotableTypeTechnology or Integration
Description

Technology partnership for data analytics and AI platform integration, enabling scalable data lakehouse architectures for life sciences customers.

Strategic tierNotableTypeTechnology or Integration
Description

Technology partnership with cloud GPU provider for molecular generation and AI model training. Joint EDM (Equivariant Diffusion Models) research initiative for 3D molecule generation using Nebius cloud H200 Nvidia GPUs.

Strategic tierNotableTypeTechnology or Integration
Description

Technology partnership for cloud data platform integration, enabling seamless data management and analytics capabilities for life sciences organizations.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1EPAM Systems
TypeDirect peer
Description

EPAM Systems is the most directly comparable peer: a large IT services and digital transformation firm with a substantial life sciences practice. Quantori's CEO Richard Golob was previously Global Head of Life Sciences at EPAM, and the CTO/CSO co-founded GGA Software Services which EPAM acquired in 2014. Direct overlap in pharma R&D informatics, data engineering, and digital services.

TypeEmerging player
Description

Benchling is a cloud-native life sciences R&D platform serving biotech and pharma with lab notebook, molecular biology, and biologics workflow software. Comparable to Quantori's Q-Suite platform ambition for R&D informatics, though Benchling focuses on SaaS lab execution while Quantori emphasizes AI/data analytics and services.

TypeDirect peer
Description

Axtria is a cloud software and data analytics company purpose-built for life sciences, providing commercial, sales, and R&D analytics platforms and services. Directly comparable in vertical focus on pharma and the combination of proprietary cloud platforms (Axtria DataMAx, Axtria SalesIQ) with implementation services.

TypeBroad incumbent
Description

Accenture operates a global Life Sciences practice delivering digital strategy, cloud, data/AI, and R&D informatics services to the largest pharma companies. Larger, broader portfolio competitor with similar GTM motion targeting enterprise pharma, but not life sciences-specialized like Quantori.

TypeEmerging player
Description

Schrödinger provides computational chemistry and molecular simulation software (LiveDesign) for drug discovery, used by major pharma companies. Overlaps with Quantori's Q-Discover molecular design capabilities and the broader push into AI-driven drug discovery, though Schrödinger is more product-pure and own-pipeline-heavy.

TypeBroad incumbent
Description

Cognizant is a global IT services giant with a dedicated Life Sciences business unit offering digital transformation, clinical operations, and R&D informatics services. Broad incumbent overlap with Quantori's service offerings, though Cognizant serves many verticals and is not life sciences-specialized.

TypeDirect peer
Description

Saama is a life sciences-focused AI and data analytics company serving biopharma with clinical and commercial data platforms. Comparable to Quantori in vertical specialization in pharma and in combining AI/ML engineering services with proprietary platform offerings (Saama Life Science Analytics Cloud).

8ZS Associates
TypeDirect peer
Description

ZS is a management consulting and technology firm dedicated to life sciences, offering analytics, AI, and software solutions to pharma clients. Comparable to Quantori's life sciences-only focus, data science depth, and mix of consulting plus proprietary software (ZS Discovery, ZS Affinity).

TypeEmerging player
Description

Insilico Medicine applies generative AI to drug discovery and has internal pipeline plus pharma partnerships. Comparable to Quantori's generative AI / molecular design work in Q-Discover, though Insilico is more product-pipeline focused and a customer/partner rather than a direct services competitor.

TypeBroad incumbent
Description

TCS is a global IT services firm with a dedicated Life Sciences & Healthcare practice offering R&D informatics, clinical data management, and digital transformation. Comparable on enterprise pharma delivery and AI/ML services scale, though much broader than Quantori's vertical focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers26 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability12 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Quantori

Life Sciences R&D Software & Digital Servicesquantori.com

Quantori is a Cambridge, MA-based software and digital services firm that builds AI-enabled solutions (Q-Suite platform) for life sciences and healthcare R&D, serving 12 of the 15 largest pharmaceutical companies plus biotech, instruments, and research clients globally.

What Quantori does

Quantori is a private, Cambridge, Massachusetts-headquartered software and digital services firm that builds AI-enabled solutions for life sciences and healthcare R&D. The company employs 750+ data scientists, data engineers, and domain experts (with more than 15% holding MDs or PhDs) and serves 12 of the 15 largest global pharmaceutical companies alongside 20+ mid-market and startup biotech clients, including Pfizer, AstraZeneca, Eli Lilly, Novartis, Bristol Myers Squibb, Takeda, Biogen, Genentech, Gilead, Syngenta, BioNTech, Bruker, PerkinElmer, LGC, and JAX.

The company's flagship product is Q-Suite, a modular agentic AI platform consisting of Q-Scientist (enterprise AI and data platform for multi-omics and LLM-powered analysis), Q-Models (ADMET prediction ML suite, co-developed with Expert Systems), Q-Portal (governed LLM deployment for regulated environments), Q-Discover (agentic drug discovery and computational chemistry), Q-HPC (computational infrastructure orchestration), Q-Data (unified life sciences data foundation), and Q-Image (4D medical imaging analytics). The platform integrates with on-prem, cloud, and hybrid environments and supports multimodal AI across text, imaging, and structured scientific data.

Quantori monetizes through a hybrid model: professional services and consulting (digital transformation, data engineering, scientific informatics, cloud engineering) and subscription/recurring revenue from Q-Suite platform products. Distribution is enterprise-direct via a 'Schedule Consultation' sales motion, complemented by AWS Advanced Services, Azure, GCP, Databricks, Snowflake, and Atlassian partnerships, AWS Marketplace listing, and a multi-channel marketing program including proprietary roundtables, industry conferences, and scientific content. The company is backed by a $15 million Flint Capital investment (October 2022) at a $100 million post-money valuation and holds ISO 27001 and AICPA SOC certifications.

Quantori firmographics

Firmographics
Name
Quantori
Legal name
Quantori, LLC
Website
https://quantori.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
251–500 employees
Short description
Quantori is a Cambridge, MA-based software and digital services firm that builds AI-enabled solutions (Q-Suite platform) for life sciences and healthcare R&D, serving 12 of the 15 largest pharmaceutical companies plus biotech, instruments, and research clients globally.
Ownership category
akta.pro rank

Quantori industry classification

Industry
Product category
Life Sciences R&D Software & Digital Services
NAICS
Custom Computer Programming Services (541511), Software Publishers (513210), Computer Systems Design Services (541512)
SIC
Services-Computer Programming Services (7371), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHDAEANAJ
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYBPAEAHAF
AI/ML Engineering & Model Development Services
SECONDARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAAACAO
Enterprise Foundation Model Integration & APIs (Connectors, Governance, Deployment)
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Foundation Models & Generative AI (LLMs, multimodal)

Keywords

  • Life sciences software
  • Drug discovery AI
  • Biopharma data science
  • R&D informatics
  • Computational chemistry platform

Where Quantori is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Quantori business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Digital Services and Consulting: End-to-end digital transformation and AI-driven solutions for life sciences and healthcare companies. Professional services including software engineering, scientific informatics, data science, and cloud engineering.
  2. Q-Suite Platform Products: AI-enabled platform products and accelerators (Q-Scientist, Q-Discover, Q-Models, Q-HPC, Q-Portal, Q-Data, Q-Image) delivered as enterprise software solutions.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Quantori product offering

Product offering

Core offering

Quantori builds and sells the Q-Suite modular agentic AI platform for life sciences R&D, comprising Q-Scientist, Q-Models, Q-Portal, Q-Discover, Q-HPC, Q-Data, and Q-Image, alongside complementary digital IT, scientific informatics, data science, cloud engineering, and software development services for pharmaceutical, biotechnology, and healthcare customers.

Product overview

Quantori offers Q-Suite, a modular agentic AI platform for life sciences R&D, consisting of core flagship accelerators (Q-Scientist, Q-Models, Q-Portal) plus additional specialized modules (Q-Discover, Q-HPC, Q-Data, Q-Image). The platform combines deep domain expertise with advanced engineering to build AI-enabled digital solutions for healthcare and life sciences. Q-Scientist serves as the enterprise AI and data platform, Q-Models provides ADMET prediction ML models, and Q-Portal governs LLM usage in regulated environments. Additional modules include Q-Discover for drug discovery workflows, Q-HPC for computational infrastructure optimization, Q-Data for unified data foundations, and Q-Image for medical imaging analysis. Quantori also offers standalone API products like the ML Conformer Generator and Deck.AI enterprise knowledge management tool.

Differentiator

Problem solved

Functional benefit

Products and services

  • Q-Scientist Enterprise-grade AI and data platform that lets scientific teams run advanced R&D workflows, from multi-omics to LLM-powered analysis, through a modular interface with secure integration into existing on-prem, cloud, or hybrid infrastructure.
  • Q-Models Comprehensive suite of machine learning models for predicting absorption, distribution, metabolism, excretion, and toxicity (ADMET) in drug discovery, delivered as a core service within the modular Q-Suite architecture.
  • Q-Portal Enterprise-ready platform for securely introducing and managing Large Language Model capabilities across pharmaceutical and healthcare organizations, providing a governed, compliance-aware environment for Generative AI with sensitive data.
  • Q-Discover End-to-end agentic AI platform that accelerates and streamlines the drug discovery and computational chemistry pipeline, integrating AI/ML molecular design, high-performance computing, and multi-agent workflow orchestration.
  • Q-HPC Agentic platform that automatically manages, optimizes, and scales computational infrastructure required for demanding scientific research, replacing manual resource allocation with intelligent, unified systems.
  • Q-Data Enterprise-grade data platform that transforms fragmented life sciences data into a unified, AI-ready foundation for accelerated discovery, with intelligent automation that eliminates data preparation bottlenecks.
  • Q-Image Unified AI-powered platform that transforms medical imaging from static moments into interactive 4-dimensional (3D space + Time) longitudinal models, integrating images from disparate sensors and sources.
  • ML Conformer Generator API Inference Server Advanced API-based solution designed to accelerate small molecule discovery through 3D shape-constrained generation of molecular conformers.
  • Deck.AI Enterprise-level knowledge management tool designed to streamline the process of creating and managing presentations for life sciences and healthcare organizations.
  • Digital Services and Consulting End-to-end digital transformation and AI-driven professional services for life sciences and healthcare customers, including software engineering, scientific informatics, data science, cloud engineering, and DevOps.

Quantifiable outcome

  • Serving 12 of 15 largest pharmaceutical companies globally
  • +3 more outcomes

Companies that use Quantori

Customer profile

Named customers26 records

Segments4 records

Ideal customer profiles4 records

Quantori technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability12 records

Feature9 records

Quantori partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core, minor and notable.

  • Decoy TherapeuticscoreStrategic or Co-development Partner · 11 March 2026Strategic partnership to deploy Google Cloud-native integrated AI-driven peptide design and molecular simulation platform. The platform integrates advanced protein folding models, molecular dynamics simulations, and AI into Decoy's proprietary IMP3ACT design engine. Expected to increase computational throughput by 25- to 100-fold.
  • Expert SystemscoreStrategic or Co-development Partner · 18 December 2025Strategic partnership to develop and integrate foundational predictive AI models for pharmaceutical research and development. Collaboration aims to improve drug discovery processes by forecasting outcomes and accelerating workflows, potentially reducing development time and costs.
  • Knowledge3minorGTM or Marketing Partner · 1 January 2025Co-marketing partnership to advance knowledge-driven AI in life sciences. Together, Quantori and Knowledge3 aim to help organizations move beyond fragmented data environments and siloed AI initiatives.
  • Google CloudcoreTechnology or IntegrationCloud platform partner providing infrastructure for AI-driven solutions. Google Cloud funding supports partnerships like the Decoy Therapeutics collaboration. Quantori is recognized as having deep GCP expertise.
  • Amazon Web Services (AWS)coreTechnology or IntegrationAWS Advanced Services Partner with over 20 years of superior software engineering skills combined with AWS technologies. Team of AWS-certified engineers with special expertise in healthcare and life sciences. Achieved 50 AWS certifications milestone.
  • Microsoft AzurecoreTechnology or IntegrationCloud platform partner offering Azure-based digital transformation and cloud consulting services for life sciences and healthcare organizations.
  • ImmuVianotableStrategic or Co-development PartnerImmuVia selected Quantori's Q-Scientist platform to streamline computational workflows across its preclinical programs for first-in-class cancer therapy development.
  • DatabricksnotableTechnology or IntegrationTechnology partnership for data analytics and AI platform integration, enabling scalable data lakehouse architectures for life sciences customers.
  • NebiusnotableTechnology or IntegrationTechnology partnership with cloud GPU provider for molecular generation and AI model training. Joint EDM (Equivariant Diffusion Models) research initiative for 3D molecule generation using Nebius cloud H200 Nvidia GPUs.
  • SnowflakenotableTechnology or IntegrationTechnology partnership for cloud data platform integration, enabling seamless data management and analytics capabilities for life sciences organizations.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Quantori competitors and assessment

Company assessment

Direct peers

  • EPAM Systems: EPAM Systems is the most directly comparable peer: a large IT services and digital transformation firm with a substantial life sciences practice. Quantori's CEO Richard Golob was previously Global Head of Life Sciences at EPAM, and the CTO/CSO co-founded GGA Software Services which EPAM acquired in 2014. Direct overlap in pharma R&D informatics, data engineering, and digital services.
  • Axtria: Axtria is a cloud software and data analytics company purpose-built for life sciences, providing commercial, sales, and R&D analytics platforms and services. Directly comparable in vertical focus on pharma and the combination of proprietary cloud platforms (Axtria DataMAx, Axtria SalesIQ) with implementation services.
  • Saama Technologies: Saama is a life sciences-focused AI and data analytics company serving biopharma with clinical and commercial data platforms. Comparable to Quantori in vertical specialization in pharma and in combining AI/ML engineering services with proprietary platform offerings (Saama Life Science Analytics Cloud).
  • ZS Associates: ZS is a management consulting and technology firm dedicated to life sciences, offering analytics, AI, and software solutions to pharma clients. Comparable to Quantori's life sciences-only focus, data science depth, and mix of consulting plus proprietary software (ZS Discovery, ZS Affinity).

Emerging players

  • Benchling: Benchling is a cloud-native life sciences R&D platform serving biotech and pharma with lab notebook, molecular biology, and biologics workflow software. Comparable to Quantori's Q-Suite platform ambition for R&D informatics, though Benchling focuses on SaaS lab execution while Quantori emphasizes AI/data analytics and services.
  • Schrödinger: Schrödinger provides computational chemistry and molecular simulation software (LiveDesign) for drug discovery, used by major pharma companies. Overlaps with Quantori's Q-Discover molecular design capabilities and the broader push into AI-driven drug discovery, though Schrödinger is more product-pure and own-pipeline-heavy.
  • Insilico Medicine: Insilico Medicine applies generative AI to drug discovery and has internal pipeline plus pharma partnerships. Comparable to Quantori's generative AI / molecular design work in Q-Discover, though Insilico is more product-pipeline focused and a customer/partner rather than a direct services competitor.

Broad incumbents

  • Accenture Life Sciences: Accenture operates a global Life Sciences practice delivering digital strategy, cloud, data/AI, and R&D informatics services to the largest pharma companies. Larger, broader portfolio competitor with similar GTM motion targeting enterprise pharma, but not life sciences-specialized like Quantori.
  • Cognizant: Cognizant is a global IT services giant with a dedicated Life Sciences business unit offering digital transformation, clinical operations, and R&D informatics services. Broad incumbent overlap with Quantori's service offerings, though Cognizant serves many verticals and is not life sciences-specialized.
  • Tata Consultancy Services (TCS): TCS is a global IT services firm with a dedicated Life Sciences & Healthcare practice offering R&D informatics, clinical data management, and digital transformation. Comparable on enterprise pharma delivery and AI/ML services scale, though much broader than Quantori's vertical focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Quantori social profiles

Digital presence

Quantori compliance and trust

Trust signal

Compliance2 records

Quantori financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Quantori leadership team

Management profile

Number of profiles

Profiles9 records

Quantori funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Quantori M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quantori

What does Quantori do?

Quantori builds and sells the Q-Suite modular agentic AI platform for life sciences R&D, comprising Q-Scientist, Q-Models, Q-Portal, Q-Discover, Q-HPC, Q-Data, and Q-Image, alongside complementary digital IT, scientific informatics, data science, cloud engineering, and software development services for pharmaceutical, biotechnology, and healthcare customers.

Is Quantori a public or private company?

Quantori is a private company. It is classified as venture growth investor backed and is currently operating.

When was Quantori founded?

Quantori was founded in 2020. It employs 251 to 500 people.

Where is Quantori based?

Quantori is headquartered in Cambridge, United States, in the North America region.

How does Quantori make money?

Two revenue lines are on record. Digital Services and Consulting is the primary driver. The others are Q-Suite Platform Products.

Who are Quantori's main competitors?

Direct peers on record are EPAM Systems, Axtria, Saama Technologies and ZS Associates. Emerging players are Benchling, Schrödinger and Insilico Medicine. Broad incumbents are Accenture Life Sciences, Cognizant and Tata Consultancy Services (TCS).

Does Quantori have an API?

Yes. Quantori offers the ML Conformer Generator API Inference Server, an advanced API-based solution designed to accelerate small molecule discovery through 3D shape-constrained generation. Additionally, the company provides API Gateway services for developing, maintaining, and publishing APIs, including deployment, monitoring, traffic management, and access control for processing concurrent API calls.

What industry is Quantori in?

Quantori's product category is Life Sciences R&D Software & Digital Services. Its primary akta.pro industry code is HDAEANAJ, AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs), with a secondary code of BPAEAHAF, AI/ML Engineering & Model Development Services. Its NAICS code is 541511 and its SIC code is 7371.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceImmuVia Selects Quantori’s Q-Scientist Platform to Accelerate Development of First-in-Class Cancer TherapyImmuVia selected Quantori's Q-Scientist platform to streamline computational workflows for its lead cancer therapy candidate IMV-M. The partnership aims to compress development timelines and reduce costs by supporting molecular modeling, in silico pharmacology, and regulatory data preparation. The collaboration targets MUC16-positive solid tumors, including ovarian and pancreatic cancers.Investing.comDecoy Therapeutics partners with Quantori on AI peptide platform By Investing.comDecoy Therapeutics Inc. announced a collaboration with Quantori to build a Google Cloud-based AI peptide design platform, aiming to increase the company's computational peptide design capacity by 25 to 100 times. The platform will integrate protein folding models, molecular dynamics simulations with GPU acceleration, and automated algorithm selection into a cloud-based infrastructure designed to work with Decoy's IMPACT design-build-test-learn engine. Separately, the company implemented a 1-for-12 reverse stock split to meet Nasdaq's $1.00 minimum listing requirement, and is collaborating with the Bill & Melinda Gates Foundation to develop a globally accessible manufacturing platform for peptide-conjugate antivirals.MorningstarDecoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation PlatformDecoy Therapeutics announced a strategic partnership with Quantori, supported by Google Cloud funding, to build a Google Cloud-native peptide design platform intended to dramatically accelerate antiviral peptide discovery. The platform will integrate advanced protein folding models, molecular dynamics simulations, and AI into Decoy's proprietary IMP³ACT design engine, with the company expecting to increase computational throughput by approximately 25- to 100-fold. The collaboration aims to advance Decoy's Designable Multi-Antivirals (D-MAVs) program, which targets single antiviral drugs effective against multiple viruses for both prevention and treatment.Stock TitanDecoy Therapeutics, Quantori build Google Cloud AI platformDecoy Therapeutics has entered a strategic partnership with Quantori, supported by funding from Google Cloud, to build a cloud-native AI-driven peptide design and molecular simulation platform. The platform is expected to increase Decoy's computational throughput by approximately 25- to 100-fold by integrating advanced protein folding models, molecular dynamics simulations, and AI tools into the company's proprietary IMP³ACT design engine. The collaboration aims to accelerate the discovery of antiviral peptide candidates designed to work across multiple viruses for both prevention and treatment.PR NewswireDecoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation PlatformDecoy Therapeutics announced a strategic partnership with Quantori, supported by Google Cloud funding, to build a cloud-native AI-driven peptide design platform for accelerating antiviral drug discovery. The platform, integrated with Google Cloud infrastructure and Quantori's Q-Suite engineering tools, is expected to increase Decoy's computational throughput by 25 to 100 times. The collaboration aims to advance Decoy's Designable Multi-Antivirals (D-MAVs) pipeline by combining machine learning, molecular dynamics simulations, and high-performance computing into a unified production-grade environment.PharmiWeb.comQuantori and Expert Systems Partner to Accelerate Drug Discovery with Foundational Predictive AI ModelsQuantori and Expert Systems announced a strategic collaboration to develop and integrate foundational predictive AI models directly into Quantori's Q-Scientist drug discovery platform. The partnership aims to help pharmaceutical and biotech clients forecast critical outcomes, accelerate candidate selection, and optimize drug development workflows, reducing time and cost of bringing new medicines to market. The alliance is expected to solidify Quantori's position in AI-driven drug development and expand Expert Systems' reach into the regulated life sciences industry.QuantoriApproaches to Multi-Omics Data IntegrationThe article outlines various approaches to multi-omics data integration, including early, mixed, intermediate, and late strategies, detailing their methodologies and associated challenges for biomedical research. It highlights how combining different omic modalities can improve understanding of biological processes like cancer development. Quantori is presented as a service provider offering bioinformatics expertise to help implement these analysis strategies.QuantoriExplainable AI for Medical Image Analysis, a Case StudyQuantori has introduced a pilot study featuring an explainable AI solution designed to assist in the detection of pulmonary edema features from radiographic images. The company utilizes a modular workflow that isolates specific lung areas and employs distinct machine learning models for different clinical signs to improve diagnostic speed and consensus among experts.FinSMEsQuantori Raises $15M in Seed FundingQuantori, a Cambridge-based IT services provider for healthcare, raised $15 million in seed funding led by Flint Capital. The company plans to use the capital to expand globally and finalize the development of a new platform supporting diagnostics, precision medicine, and drug discovery. Quantori currently serves major pharmaceutical clients including Pfizer, AstraZeneca, Takeda, and Biogen.TechCrunchQuantori is building an app development platform focused on life sciencesQuantori, a startup based in Cambridge, Massachusetts, announced a $15 million seed investment to develop a platform-as-a-service tailored for the life sciences sector, especially biopharma companies. The platform aims to reduce drug discovery time and costs, with over 30 major clients including Pfizer and AstraZeneca, and is expected to generate around $30 million in revenue in the current year.